Immunic
IMUX
$1.24
Share price
-0.40%
Change (1 day)
-31.22%
Change (1 year)
Categories
Immunic (IMUX) - Cash on Hand
Cash on Hand as of December 2023 : $46.67 M
According to Immunic's latest financial reports the company has $46.67 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Immunic - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $46.67 M | -59.89% |
| 2022-12-31 | $0.11 B | 33.97% |
| 2021-12-31 | $86.86 M | -31.85% |
| 2020-12-31 | $0.12 B | 333.97% |
| 2019-12-31 | $29.36 M | 120.42% |
| 2018-12-31 | $13.32 M | -76.58% |
| 2017-12-31 | $56.9 M | -5.15% |
| 2016-12-31 | $59.99 M | -28.08% |
| 2015-12-31 | $83.41 M | -18.41% |
| 2014-12-31 | $0.10 B | 167.74% |
| 2013-12-31 | $38.18 M | 106.71% |
| 2012-12-31 | $18.47 M | 2200.5% |
| 2011-12-31 | $0.8 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 346.04% | 🇺🇸 USA |